You are viewing an expired study

This study is not currently recruiting Study Participants on If you would like to find active studies please browse nearby listings below.

Click here to view additional nearby studies or search for clinical trials.

Fort Sam Houston, Texas 78234

  • Burns


The purpose of this study is to compare one type of dressing against the current standard dressing that is used to cover an unburned area of the skin where a piece of skin is removed to cover another part of the body that was burned. Hypothesis: The mean healing time for wounds treated with the Silverlon Dressing will be less than the mean healing time for wounds treated with Xeroform Dressing.

Study summary:

At the time of the procedure, donor sites that are symmetrical in size and shape will be selected. Once the grafts have been harvested, the wounds will be randomized for treatment using either the Silverlon dressing or Xeroform. The wound dressings will then be observed at least once a day beginning 72 hours after surgery until healed, defined as 90% or more of the wound surface being confluently re-epithelized.


Inclusion Criteria: - 18 years or older; male or female. - Burn wounds of less than 30% total body surface area (TBSA) with no systemic abnormalities - Burns do not involve the harvesting area - Burn wounds require excision and grating of sufficient extent to justify two donor sites of equal and symmetrical size on non-dependent body surface areas - Scheduled excision and grafting procedures is the first such operation for subject during this hospitalization - Subject agrees to participate in follow-up evaluations Exclusion Criteria: - Critical illnesses requiring ventilator support, systemic infection or hemodynamic instability - Major acute or chronic illnesses affecting wound healing (e.g. peripheral vascular disease, insulin dependent diabetes, blood clotting disorder) - Subject receiving medications that inhibit/compromise wound healing (e.g. anticoagulants, antiplatelet drugs, oral steroids). The use of anticoagulants does not include deep vein thrombosis (DVT) prophylaxis. - Cellulitis or other infection of potential donor site - Previously harvested donor site - Subject with greater than 30% TBSA burns - Subjects with sensitivity to silver or nylon - Pregnancy



Primary Contact:

Principal Investigator
Michael Albrecht, MD
US Army Institute of Surgical Research

Backup Contact:


Location Contact:

Fort Sam Houston, Texas 78234
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: March 26, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.